It was documented that CD47 blockade could trigger macrophage‐mediated elimination of non‐small cell lung cancer (NSCLC) cells with resistant to EGFR tyrosine kinase inhibitors (TKIs), and eliciting synergistic anti‐tumour effect with TKIs.5, 14. Here, CD47 is linked to neoplasm.